LDL
Showing 1 - 25 of 7,880
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
To Reduce the LDL-C Level in Hypercholesteremia Patients Trial (RN0191)
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Patients
- (no location specified)
Nov 13, 2023
Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)
Not yet recruiting
- Hypercholesterolemia
- Dyslipidemias
- lipodia
-
Hamburg, GermanyGAIA AG
Aug 3, 2023
Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid), Placebo)
Recruiting
- Hyper-low-density Lipoprotein (LDL) Cholesterolemia
- 180mg of ETC-1002(bempedoic acid)
- Placebo
-
Izumisano-shi, JapanRinku General Medical Center
Jan 4, 2023
Categories and Attaining LDL-C Targets in Middle Eastern Adults
Not yet recruiting
- Atherosclerotic Cardiovascular Risk
- Low-density-lipoprotein (LDL) Cholesterol
- (no location specified)
Feb 16, 2023
Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid))
Recruiting
- Hyper-low-density Lipoprotein (LDL) Cholesterolemia
- 180mg of ETC-1002(bempedoic acid)
-
Izumisano-shi, JapanRinku General Medical Center
Jan 13, 2023
Different Equations to Accurately Calculate LDL Cholesterol
Active, not recruiting
- Dyslipidemias
- Lipid Disorder
- no intervention, Serum LDL cholesterol calculation
-
Bron, FranceLaboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- (no location specified)
Mar 17, 2023
Diet-induced Elevations in LDL-C and Progression of
Recruiting
- Hypercholesterolemia
-
Torrance, CaliforniaLundquist Institute for Biomedical Innovation at Harbor UCLA Med
Feb 17, 2023
Hypercholesterolemia Trial in Lille (Plant food supplement, Maltodextrin)
Completed
- Hypercholesterolemia
- Plant food supplement
- Maltodextrin
-
Lille, FranceNutrINvest
Dec 6, 2022
LDL-Apheresis for FSGS CardioRenal Outcomes
Enrolling by invitation
- Focal Segmental Glomerulosclerosis
- No intervention
-
Cincinnati, Ohio
- +1 more
Jan 25, 2023
Cardiovascular Diseases, Hyper-LDL-cholesterolemia Trial in Cincinnati (lerodalcibep)
Active, not recruiting
- Cardiovascular Diseases
- Hyper-LDL-cholesterolemia
-
Cincinnati, Ohio
- +2 more
Nov 3, 2022
Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)
Active, not recruiting
- Above Optimal Plasma LDL Concentrations
- muffin
-
Winnipeg, Manitoba, Canada
- +1 more
Oct 24, 2022
Cardiovascular Diseases Trial (Meal timing)
Recruiting
- Cardiovascular Diseases
- Meal timing
-
Bath, United KingdomDepartment for Health, University of Bath
Oct 10, 2022
To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
- Combination for Subgroup High LDL-c Patients With Other Comorbidities
- RN0191 INJECTION
- (no location specified)
Jun 14, 2023
Cardiovascular Health Trial in Alhendín (Garlic and onion concentrate, Control)
Recruiting
- Cardiovascular Health
- Garlic and onion concentrate
- Control
-
Alhendín, Granada, SpainDomca Sau
May 20, 2022
LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)
Recruiting
- LDL-cholesterol
- statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
-
Jena, Thuringia, GermanyUniversity Hospital Jena
Oct 17, 2022
Cardiovascular Disease Trial in Seoul (Intensive targeting group, Conventional therapy group)
Recruiting
- Cardiovascular Disease
- Intensive targeting group
- Conventional therapy group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 7, 2022
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
Healthy Trial in Parma (Bergamot Juice)
Recruiting
- Healthy
- Bergamot Juice
-
Parma, ItalyUniversity of Parma, Department of Medicine and Surgery
Oct 18, 2022
Hypercholesterolemia, Primary Prevention Trial in Sao Paulo (Phytosterol supplements)
Completed
- Hypercholesterolemia
- Primary Prevention
- Phytosterol supplements
-
Sao Paulo, Other, Brazil
- +1 more
Nov 9, 2023
LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease
Not yet recruiting
- LDL Hyperlipoproteinemia
- +2 more
- omega-3 fatty acids
- Placebo
-
Novosibirsk, Novosibisk Region, Russian FederationCenter of New Medical Technologies
Nov 30, 2023
Human Immunodeficiency Virus (HIV) Infection, Hypercholesterolemia Trial in Columbus (Soy Pretzel, Wheat Pretzel)
Recruiting
- Human Immunodeficiency Virus (HIV) Infection
- Hypercholesterolemia
- Soy Pretzel
- Wheat Pretzel
-
Columbus, OhioThe Ohio State University Medical Center
Sep 19, 2022
Oxidized Low Density Lipoprotein Trial in Fort Lauderdale (Cardio formulation, Placebo)
Terminated
- Oxidized Low Density Lipoprotein
- Cardio formulation
- Placebo
-
Fort Lauderdale, FloridaLfie Extension Clinical Reseach, Inc.
Jan 12, 2023
Hypercholesterolemia Trial in Bologna (Eufortyn Colesterolo Plus, Placebo)
Completed
- Hypercholesterolemia
- Eufortyn Colesterolo Plus
- Placebo
-
Bologna, ItalyAOU Policlinico S.Orsola-Malpighi
Jul 25, 2022